Bevespi

glycopyrronium and formoterol fumarate single inhaler combination

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bevespi, covering 2021-01-19 to 2021-01-19. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI [Phase 2, Phase 3]